The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Tolebrutinib, an experimental drug, slowed disability progression in advanced MS by 31% in a major trial, offering hope for ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

An experimental drug may slow the progression of a form of multiple sclerosis that increases disability relentlessly, a new study finds. There are currently no FDA-approved treatments for ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, ...

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

Neurodegenerative disorders have increasing incidence with limited treatment options. Approaches to target neuroinflammation in various neurodegenerative disorders, such as Alzheimer’s disease (AD), ...